Case File
efta-02381350DOJ Data Set 11OtherEFTA02381350
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02381350
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Giuffrida, David
Sent:
Monday, May 21, 2012 2:03 PM
To:
Jeffrey Epstein
Cc:
Barrett, Paul S
Subject:
FB
Jeffrey,
c=p>
Facebook is now trading -33=2E90, down - $4.30 on the morning. There was some support @ 33.=nbsp; No color from
our trading desk, they still don't see any buyer= stepping up.
Please let us know if you'd like to do something with=your 35,000 shares.
David J. Giuffrida
J=2EP. Morgan I Global Investment Opportunities Group
=OD
320 Park Avenue, 14th=Floor
New York, NY 10022
=OA
=OD
This communication is for informat=onal purposes only. It is not intended as an offer or solicitation for t=e purchase or
sale of any financial instrument or as an official confirmat=on of any transaction. All market prices, data and other
information are=not warranted as to completeness or accuracy and are subject to change wit=out notice. Any
comments or statements made herein do not necessarily re=lect those of JPMorgan Chase & Co., its subsidiaries and
affiliates.=0D This transmission may contain information that is privileged, c=nfidential, legally privileged, and/or exempt
from disclosure under applic=ble law. If you are not the intended recipient, you are hereby notified =hat any disclosure,
copying, distribution, or use of the information conta=ned herein (including any reliance thereon) is STRICTLY
EFTA_R1_01396173
EFTA02381350
PROHIBITED. Alth=ugh this transmission and any attachments are believed to be free of any v=rus or other defect that
might affect any computer system into which it is=received and opened, it is the responsibility of the recipient to ensure
t=at it is virus free and no responsibility is accepted by JPMorgan Chase & =o., its subsidiaries and affiliates, as
applicable, for any loss or dama=e arising in any way from its use. If you received this transmission in =rror, please
immediately contact the sender and destroy the material in it= entirety, whether in electronic or hard copy format.
Thank you. =OD Please refer to http://www.jpmorgan.com/pages/disclosures for dis=losures relating to European legal
entities.
2
EFTA_R1_01396174
EFTA02381351
Technical Artifacts (3)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Phone
2381350Phone
2381351URL
http://www.jpmorgan.com/pages/disclosuresRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.